CHRONIC STABLE ILLNESS
Clinical trials for CHRONIC STABLE ILLNESS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC STABLE ILLNESS trials appear
Sign up with your email to follow new studies for CHRONIC STABLE ILLNESS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can antibodies and vaccine team up safely?
⭐️ VACCINE ⭐️ CompletedThis study looked at whether giving a COVID-19 antibody treatment (casirivimab+imdevimab) along with the Moderna vaccine changes how well the vaccine works. About 295 healthy adults took part. The goal was to see if the timing between the antibody treatment and the vaccine matter…
Matched conditions: CHRONIC STABLE ILLNESS
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 09:27 UTC
-
New antibody combo tested for safety in healthy volunteers
Disease control CompletedThis early-stage study tested the safety of a combination of two antibodies (casirivimab and imdevimab) against the COVID-19 virus. It involved 45 healthy adults or those with stable chronic conditions. The goal was to see if the treatment is safe and how the body processes it.
Matched conditions: CHRONIC STABLE ILLNESS
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 09:35 UTC